Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Neurogenic Overactive Bladder

NCT00311376 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
416
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Allergan